With $850m, Nuvation Aims To Speed Novel Cancer Drugs To Patients
As With Medivation, David Hung Takes New Venture Public In SPAC Merger
Nuvation started in 2018 and raised a $275m series A round in 2019. Now it is merging with the EcoR1 Capital-sponsored SPAC Panacea Acquisition Corp. and raising $500m in equity capital.
